ABEONA THERAPEUTICS INC. Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination
ABEONA THERAPEUTICS INC. (ABEO) reported Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination of $677.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2026-06-30 was $252.00K.
- ABEONA THERAPEUTICS INC. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2026-03-31 was $425.00K.
| Period end | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 3 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 6 month |
|---|---|---|
| 2026-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $677.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $425.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |